Wakefit Innovations Ltd

BSE: 544642

88

total announcements

WAKEFIT.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 27 Oct 2026

Market Cap

₹4,423 Cr

P/E (TTM)

22.7

P/E (Forward)

32.9

EPS (TTM)

₹5.88

52W Low

₹111.40

52W High

₹224.00

Dividend Yield

0.00%

Price / Book

3.9

Debt / Equity

24.0

Revenue (TTM)

₹1,547 Cr

Gross Margin

56.10%

Operating Margin

6.93%

BSECompany Update▲ PositiveResults6 Aug 2026

Wakefit Innovations Ltd

Press release in relation to the unaudited financial results for the quarter ended June 30, 2026

Wakefit Innovations Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations increasing by 16.6% YoY to INR 4,049.1 million, and reported EBITDA (excluding Other Income) increasing to INR 564.0 million, with an EBITDA margin of 13.9%. Profit Before Tax rose to INR 363.1 million, an increase of 85.1% YoY, while Profit After Tax for the quarter stood at INR 233.8 million, registering a YoY increase of 19.2%. The company has also added 27 new stores during the quarter, taking the total active COCO stores to 165.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Aug 2026

Wakefit Innovations Ltd

Outcome of the Board Meeting held on August 6, 2026

Wakefit Innovations Ltd has announced the outcome of its board meeting held on August 6, 2026, where the board approved the unaudited financial results for the quarter ended June 30, 2026. The results along with the limited review report by the statutory auditors, M/s. B S R & Co. LLP, are available on the company's website.

Read more →📎 1 attachment
BSECompany UpdateResults3 Aug 2026

Wakefit Innovations Ltd

Intimation of Earnings Conference Call for Q1 FY27

Wakefit Innovations Ltd has announced an earnings conference call for Q1 FY27, to be held on August 07, 2026, at 10:30 a.m. (IST). The conference call will be attended by the management team, and the unaudited financial results for the quarter ended June 30, 2026, will be discussed.

Read more →📎 1 attachment
← PreviousPage 5 of 5